Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Toward a Pill to Enable… >
Toward a Pill to Enable Celiac Patients to Eat Foods Containing Gluten

Published: December 19, 2012.
By American Chemical Society
http://www.acs.org

Scientists are reporting an advance toward development of a pill that could become celiac disease's counterpart to the lactase pills that people with lactose intolerance can take to eat dairy products without risking digestive upsets. They describe the approach, which involves an enzyme that breaks down the gluten that causes celiac symptoms, in the Journal of the American Chemical Society.

Justin Siegel, Ingrid Swanson Pultz and colleagues explain that celiac disease is an autoimmune disorder in which the gluten in wheat, rye or barley products causes inflammation in the digestive tract. Enzymes in the stomach break down gluten into smaller pieces, called peptides. For most people, these peptides are harmless. But for the 2 million-3 million Americans with celiac disease, the peptides trigger an autoimmune response and painful symptoms. Currently, the only treatment is a gluten-free diet. However, the scientists reasoned that if an enzyme could further break down the offending peptides in the stomach, celiac patients might be able to eat gluten-containing foods.

They describe discovery of a naturally occurring enzyme that has some of the ideal properties for doing so. The scientists modified the enzyme in the laboratory so that it would meet all the necessary criteria. The new enzyme (called KumaMax) broke down more than 95 percent of a gluten peptide implicated in celiac disease in acidic conditions like those in the stomach. "These combined properties make the engineered [enzyme] a promising candidate as an oral therapeutic for celiac disease," say the researchers.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Disease 
5/9/10 
Scripps Research Scientists Shed Light on Potential Treatment for Gaucher's Disease
By Scripps Research Institute
LA JOLLA, CA – May 7, 2010 – In findings that advance scientists' understanding of a whole class of inherited disorders, a team from The Scripps Research Institute has …
Treatment 
10/19/10 
★★★★ 

Cheaper, More Effective Treatment of Type 1 Gaucher Disease Possible
By Yale University
Retinopathy 
1/13/11 

Enzyme Inhibition Or Removal May Prevent Or Treat Ischemic Retinopathy
By Medical College of Georgia
Disease 
10/11/12 
Anti-cancer Drug Fights Immune Reaction in Some Infants with Pompe Disease
By Duke University Medical Center
DURHAM, N.C. – Adding a third anti-cancer agent to a current drug cocktail appears to have contributed to dramatic improvement in three infants with the most severe form of …
Inhibitors 
6/13/12 
Researchers Design New Substances That Might Help Fight Alzheimer's And Parkinson's Disease
By University of Granada
This enzyme is also involved in other conditions as inflammatory bowel disease or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease and amyotrophic lateral sclerosis. …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.